ECM
PJP icon

Exchange Capital Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Exchange Capital Management’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-444
Closed -$27K – 216
2016
Q3 		$27K Buy
+444
New +$29.1K 0.01% 130

Other funds holding PJP

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PAM
Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Exchange Capital Management's PJP Position: Q4 2016 in Review

Exchange Capital Management sold out of Invesco Pharmaceuticals ETF (PJP) in Q4 2016, closing a stake of 444 shares — an estimated $27K sold.

Exchange Capital Management first reported a position in PJP in Q3 2016 and held it in 1 quarter. The position peaked at $27K in Q3 2016. 101 funds tracked by Wall St. Rank hold PJP as of Q4 2016.

  • Exchange Capital Management reported no remaining Invesco Pharmaceuticals ETF position as of Q4 2016 after selling out during the quarter.
  • Exchange Capital Management sold 444 Invesco Pharmaceuticals ETF shares in Q4 2016, an estimated $27K.
  • Exchange Capital Management first reported a position in Invesco Pharmaceuticals ETF in Q3 2016 and held it in 1 quarter.
  • Exchange Capital Management's Invesco Pharmaceuticals ETF position peaked at $27K in Q3 2016.
  • 101 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q4 2016.

Based on Exchange Capital Management's 13F filing for Q4 2016, filed 13 Feb 2017.